ENCell announces promising results from Phase 1 CMT1A trial of EN001

ENCell Co., Ltd., a South Korean biotech leader specializing in Cell and Gene Therapy (CGT), has unveiled promising results from their first-in-human Phase 1 clinical ... Read More